Literature DB >> 16190834

Laparoscopic and open surgical nephrectomy for xanthogranulomatous pyelonephritis.

Herkanwal S Khaira1, Rajal B Shah, J Stuart Wolf.   

Abstract

BACKGROUND AND
PURPOSE: Xanthogranulomatous pyelonephritis (XGP) is a severe, chronic renal-parenchymal infection. Nephrectomy is the treatment of choice. Because of the renal and perirenal inflammatory changes that commonly accompany XGP, the laparoscopic approach is difficult. We compared our experience with laparoscopic and open surgical nephrectomy for XGP. PATIENTS AND METHODS: A retrospective chart review of all adult nephrectomy specimens with the pathologic diagnosis of XGP between January 1997 and May 2003 was performed. Preoperative presentation, operative details, and postoperative recovery and complications were included in the data collection.
RESULTS: Three patients approached laparoscopically and eight patients approached with open surgery were found to have XGP on pathologic analysis. The disease was suspected preoperatively in all patients. Among the laparoscopically treated patients, there was 1 (33%) who suffered major complications; this was the only patient who required conversion to open surgery. Among the open-surgical group, there were 2 (22%) major and 3 (33%) minor complications. Postoperative hospitalization was longer in the open-surgical group (mean 13.7 v 4.7 days), and when the case of open conversion was excluded, narcotic use was less in the laparoscopy group.
CONCLUSIONS: The treatment of some XGP cases with laparoscopic nephrectomy is a possible, albeit challenging, option. The incidences of intraoperative and postoperative complications were roughly equivalent in the laparoscopic and open-surgery patients in our study. If completed, laparoscopy appears to be associated with decreased postoperative morbidity. However, this may represent selection bias, and larger, prospective studies may better define the suspected benefit.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16190834     DOI: 10.1089/end.2005.19.813

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  8 in total

Review 1.  Laparoscopic renal surgery for benign disease.

Authors:  Joseph C Liao; Alberto Breda; Peter G Schulam
Journal:  Curr Urol Rep       Date:  2007-01       Impact factor: 3.092

Review 2.  Xanthogranulomatous pyelonephritis: a review and meta-analysis with a focus on management.

Authors:  Paul Gravestock; Lauren Moore; Chris Harding; Rajan Veeratterapillay
Journal:  Int Urol Nephrol       Date:  2022-07-09       Impact factor: 2.266

3.  Minimally invasive nephrectomy for inflammatory renal disease.

Authors:  Paula Andrea Peña; Lynda Torres-Castellanos; Germán Patiño; Stefanía Prada; Luis Gabriel Villarraga; Nicolás Fernández
Journal:  Asian J Urol       Date:  2019-09-14

4.  Xanthogranulomatous pyelonephritis: a comparison of open and minimally-invasive surgical approaches.

Authors:  Marcelo Panizzutti Barboza; Charles U Nottingham; Adam C Calaway; Ting Wei; Chandra K Flack; Clint Cary; Ronald S Boris
Journal:  J Robot Surg       Date:  2020-09-30

5.  Laparoscopic versus open nephrectomy for xanthogranulomatous pyelonephritis: An outcome analysis.

Authors:  Kartik J Shah; Arvind P Ganpule; Abraham Kurien; Veeramani Muthu; Ravindra B Sabnis; Mahesh R Desai
Journal:  Indian J Urol       Date:  2011-10

6.  Laparoscopic nephrectomy outside gerota fascia and En bloc ligation of the renal hilum for management of inflammatory renal diseases.

Authors:  Liang Ma; Yanlan Yu; Guangju Ge; Gonghui Li
Journal:  Int Braz J Urol       Date:  2018 Mar-Apr       Impact factor: 1.541

7.  Laparoscopic nephrectomy in xanthogranulomatous pyelonephritis.

Authors:  Murad Asali; Alexander Tsivian
Journal:  Cent European J Urol       Date:  2019-08-05

8.  The role of laparoscopic nephrectomy in pediatric xanthogranulomatous pyelonephritis: a case report.

Authors:  James F Brown; Jennifer C Chamberlain; Christopher C Roth
Journal:  Case Rep Urol       Date:  2013-02-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.